je.st
news
Tag: pharmaceuticals
Dechra Pharmaceuticals plc's (DPH) "Buy" Rating Reiterated at Stifel Nicolaus
2016-03-21 22:08:33| Automakers - Topix.net
's stock had its "buy" rating reaffirmed by equities researchers at Stifel Nicolaus in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. They presently have a GBX 1,280 price target on the stock.
Tags: buy
rating
pharmaceuticals
plcs
Valeant Pharmaceuticals Stock: Buy On The Drop?
2016-03-16 13:40:49| Semiconductors - Topix.net
This article is my 18th installment in a segment called "Buy on the Drop?" where I choose a stock that recently experienced a large decrease in price and give a recommendation on whether investors should "Buy on the Drop" or not. This is a recurring segment, so if you enjoy the article, "Follow" me to see more.
Tags: buy
stock
drop
pharmaceuticals
Nordea Investment Management AB Buys 1,346 Shares of Vertex Pharmaceuticals Incorporated
2016-03-06 01:21:01| Biotech - Topix.net
Nordea Investment Management AB raised its stake in Vertex Pharmaceuticals Incorporated by 15.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The fund owned 9,947 shares of the pharmaceutical company's stock after buying an additional 1,346 shares during the period.
Tags: management
investment
incorporated
shares
Equities Analysts Issue Forecasts for Lexicon Pharmaceuticals, Inc.'s FY2020 Earnings
2016-03-04 04:50:54| Biotech - Topix.net
Lexicon Pharmaceuticals, Inc. - Stock analysts at Wedbush issued their FY2020 earnings per share estimates for shares of Lexicon Pharmaceuticals in a research report issued on Tuesday, according to Zacks Investment Research . Wedbush analyst L. Moussatos forecasts that the firm will earn $2.71 per share for the year.
Tags: issue
earnings
analysts
forecasts
Valeant Pharmaceuticals Intl Inc (VRX) Position Lowered by TD Asset Management Inc.
2016-03-03 10:04:42| Biotech - Topix.net
TD Asset Management Inc. reduced its stake in shares of Valeant Pharmaceuticals Intl Inc by 11.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,944,449 shares of the specialty pharmaceutical company's stock after selling 260,056 shares during the period.
Tags: inc
management
position
asset
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »